Education
About Us
Working with TipRanks
Follow Us
Daniel Tillett Insider Profile
25 Followers
Daniel Tillett, Chief Scientific Officer at Race Oncology Ltd., holds 62.00M shares in Tryptamine Therapeutics (Ticker: AU:TYP), holds 44.19M shares in Simble Solutions Ltd. (Ticker: AU:SIS), holds 16.00M shares in Race Oncology Ltd. (Ticker: AU:RAC). Most recently, Daniel Tillett Bought ― shares of Tryptamine Therapeutics on Mar 31, 2025 for an estimated value of 1.00M.
Daniel Tillett Race Oncology Ltd. (RAC)Chief Scientific Officer
Race Oncology Ltd. (RAC)
Chief Scientific Officer
Ranked #180 out of 102,596 Corporate Insiders
Profitable Transactions
3 out of 14 Profitable Transactions
Average Return
+132.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Tillett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Tillett
Daniel Tillett's Trading History
Race Oncology Ltd.
Feb 07, 2023
Chief Scientific Officer
Informative Buy
13.04K
AU$18.40M
Simble Solutions Ltd.
Mar 28, 2023
Director
Informative Buy
50.00K
―
Tryptamine Therapeutics
Mar 31, 2025
Director
Informative Buy
1.00M
AU$1.98M
List of latest transactions for each holding click on a transaction to see Daniel Tillett's performance on stock
You May Also Like
Daniel Tillett insider profile FAQ
What is the percentage of profitable transactions made by Daniel Tillett?
The percentage of profitable transactions made by Daniel Tillett is 21%.
What is the average return per transaction made by Daniel Tillett?
The average return per transaction made by Daniel Tillett is 132.60%.
What stocks does Daniel Tillett hold?
Daniel Tillett holds: AU:RAC, AU:SIS, AU:TYP stocks.
What was Daniel Tillett’s latest transaction?
Daniel Tillett latest transaction was an Informative Buy of AU$1.00M.
What was Daniel Tillett's most profitable transaction?
Daniel Tillett’s most profitable transaction was an Informative Buy of AU:RAC stock on December 5, 2019. The return on the trade was 800.00%.
What is Daniel Tillett's role in Race Oncology Ltd.?
Daniel Tillett's role in Race Oncology Ltd. is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.